FibroGen, Inc. (FGEN)
NASDAQ: FGEN · IEX Real-Time Price · USD
1.050
+0.010 (0.96%)
Jul 19, 2024, 4:00 PM EDT - Market closed
FibroGen Market Cap
FibroGen has a market cap or net worth of $104.45 million as of July 22, 2024. Its market cap has decreased by -62.18% in one year.
Market Cap
104.45M
Enterprise Value
129.02M
1-Year Change
-62.18%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $104.45M, a decrease of -91.47%. That is a compound annual growth rate of -22.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 104.40M | 19.86% |
| Dec 29, 2023 | 87.10M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regulus Therapeutics | 108.02M |
| CytomX Therapeutics | 107.53M |
| Zentek | 106.80M |
| Coya Therapeutics | 106.55M |
| InterCure | 104.82M |
| IO Biotech | 104.09M |
| Eledon Pharmaceuticals | 103.97M |
| Oramed Pharmaceuticals | 103.60M |